ZimVie Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Vafa Jamali
- Full Time Employees
- 1,770
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 10225 Westmoor Drive Palm Beach Gardens CO United States of America 80021
- IPO Date
- Feb 16, 2022
- CIK
- 0001876588
- Website
- zimvie.com
- Similar Companies
- Business
- ZimVie Inc. (Nasdaq: ZIMV) develops, manufactures and markets a comprehensive portfolio of dental implant systems, biomaterials, restorative solutions and digital workflows to support tooth replacement and restoration procedures for oral surgeons, clinicians and dental laboratories worldwide. The company offers implant platforms including Trabecular Metal, Tapered Screw-Vent, Certain, TSV and TSX implants; prosthetic components such as abutments, GenTek restorative components, Azure multi-platform solutions and full-arch rehabilitation systems like BellaTek, OverdenSURE and SmileToday; regenerative biomaterials including Puros allografts, Biotivity A/C Plus Membrane and custom blocks; and digital dentistry technologies encompassing intraoral scanners, RealGUIDE surgical planning software, guided surgery solutions and CAD/CAM workflows. ZimVie operates globally across more than 70 countries from its headquarters in Palm Beach Gardens, Florida, with additional facilities in the U.S., Europe, Asia and other regions; it traces its heritage to a 2022 spin-off from Zimmer Biomet Holdings Inc., incorporating legacies from Biomet (founded 1977) and Zimmer (founded 1927). In October 2025, ZimVie completed its acquisition by ARCHIMED, a Lyon-based healthcare investment firm, for approximately $730 million at $19.00 per share, transitioning to a privately held entity and delisting from Nasdaq; the company had previously sold its spine business to H.I.G. Capital in 2024 for $375 million to focus exclusively on dental solutions. Recent innovations include the U.S. launch of the next-generation TSX Implant and Immediate Molar Dental Implant System for enhanced primary stability and molar restoration; FDA clearance and U.S. introduction of GenTek Restorative Components; the Azure multi-platform product solutions and Biotivity A/C Plus Membrane for regenerative procedures; and an exclusive distribution agreement with Osstem Implant to expand premium offerings in China.
ZimVie Announces Completion of its Acquisition by ARCHIMED
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV and CIO on Behalf of Shareholders
ZimVie Reports Second Quarter 2025 Financial Results
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ZimVie Inc. (NASDAQ: ZIMV)
Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders
ZIMV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ZimVie Inc. Is Fair to Shareholders
ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash
ZimVie: Screening Cheap (Rating Upgrade)
ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite
ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan
ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
ZimVie Reports First Quarter 2025 Financial Results
ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025